Vaccine Quality Challenges in Secretly Traded H5 and H9 Avian Influenza Vaccines in Nigeria

Abstract

Avian Influenza Virus (AIV) especially the highly pathogenic subtype H5Nx causes Avian Influenza (AI) disease and it is a major threat to  the poultry industry and public health worldwide. Vaccination is one of the control measures in many countries, though restricted in  Nigeria. As such, some poultry farmers secretly employ imported H5 and H9 AI vaccines to vaccinate their chickens. This study investigated the antigenic quality of these imported vaccines. Four imported vaccine brands were tested using Hemagglutination (HA)  test and Reverse Transcriptase Polymerase Chain Reaction (RTPCR). All four vaccine samples tested negative in the HA test, indicating a  lack of detectable HA antigen titer. Similarly, RT-PCR failed to amplify the targeted region of the viral matrix gene in any of the vaccine  samples against reference control. These negative results are of great concern and suggest that the imported H5 and H9 vaccines lack  essential antigens that could stimulate antibodies. Thus, potentially rendering them ineffective against circulating AI subtypes. The failure  in antigenic quality could be due to myriads of factors including improper storage, transport (often due to illegal import), or  limitations in the original vaccine production process. Regardless of the specific cause, these findings highlight the potential risks  associated with the use of unregulated vaccines. Poultry farmers who use these imported vaccines may be incurring unnecessary costs  while receiving a false sense of security for their flocks. In conclusion, due to the apparent lack of efficacious antigens, we suggest a  quality monitoring of imported H5 and H9 vaccines in Nigeria for compliance with local regulations on vaccine use, biosecurity measures  and investigation into the root causes of the vaccine failure observed in this study.